Publications
TIL Cells
G-Rex®10, G-Rex®10M
Publication Date: February 2, 2022
Adding agonistic anti-CD3 and anti-4-1BB (urelumab) stimulation to high-dose IL-2 during initial culture expanded tumor-infiltrating lymphocytes (TIL) from all 16 resected non-small cell lung cancer tumors tested, compared with 62.5% using IL-2 alone. Fragments from each tumor were grown in parallel with both methods. The three-signal method (TIL 3.0) produced a median of 186.3 × 10^6 versus 18.5 × 10^6 TIL in a median of 14 versus 27.5 days, with 86.43% versus 29.67% CD8+ cells. Its TCR repertoire was broader (median 3032 versus 1046 clonotypes), more similar to the tumor, and retained more putative tumor-specific TCR (median 20.31% versus 6%). A subsequent rapid expansion protocol reduc…
Publications
Other, T-Cells
G-Rex®100M, G-Rex®10M, G-Rex®6M Well Plate
Publication Date: January 19, 2022
G-Rex® gas-permeable devices allowed polyclonal T cell products for clinical use to be expanded faster and with far less handling than standard T-flasks. Cytokine-induced killer cells (CIKs) and blinatumomab-expanded T cells (BETs) reached more than 30 × 10^6 CD3+ cells/cm² in about 10 to 11 days, versus 21 days in flasks. Starting from 5 × 10^6 PBMCs in a G-Rex® 10M, CIK cultures yielded a mean of 300 × 10^6 CD3+ T cells, against 110 × 10^6 in flasks. G-Rex® CIKs had a phenotype similar to flask CIKs, with lower CD56 and higher CD27 and CD28, were cytotoxic against K562 and REH cells, showed activity in a pre-B-ALL mouse model and did not induce GvHD in NSG mice. GMP validation batches o…
Publications
CAR T Cells
Publication Date: January 11, 2022
A chimeric antigen receptor built from the BAFF ligand gave a single T cell product the ability to engage BAFF-R, BCMA and TACI and to kill mantle cell lymphoma, acute lymphoblastic leukemia and multiple myeloma cells. The receptor was delivered without a virus, using the TcBuster transposon system, and the engineered T cells were expanded in gas-permeable rapid expansion vessels. At a 5:1 effector:target ratio, 69% of Jeko-1 and 57% of rs4;11 cells were killed, while HEK293T lines engineered to express any single BAFF receptor were lysed and parental cells were spared. Transposon copy number stayed below 10 copies per CAR-positive cell and clonal outgrowth was low. In mice, treated anima…
Publications
CAR T Cells
G-Rex®6M Well Plate
Publication Date: January 8, 2022
Memory T cells depleted of CD45RA and CD14 can be turned into CD19-CAR T cells under a cGMP-compliant process intended for a planned allogeneic clinical trial. Apheresis cells from four healthy donors yielded 4.9% of processed cells after depletion, and 94.5% of nucleated cells were CD3-positive. After TransAct activation and lentiviral transduction, with or without LentiBOOST, cells expanded in G-Rex® 6M plates with 100 mL per well and were harvested on day 7 or 8. LentiBOOST raised CAR expression and vector copy number without changing expansion. Products were mostly CD4-positive effector memory cells, retained virus specificity, killed CD19-positive BV173 cells, and matched standard CD…
Publications
Other
Publication Date: January 1, 2022
A low-cost, portable readout for spiral-coil LC resonant sensors was built from off-the-shelf components on a four-layer printed circuit board, avoiding an expensive vector network analyzer. It uses coherent demodulation to detect the peak in the real part of the reader coil's input impedance, with a direct digital synthesizer sweeping 1 to 100 MHz. The board consumes 1.26 W. With a 4 cm single-loop reader coil and a sensor coil over deionized water, the readout peaked at 11.0 MHz, matching a network analyzer at 2 cm. Tracking cooling deionized water, it followed temperature up to 5 cm, with a linear fit R-squared of 0.99 and under 0.33% maximum error relative to the mean; peak detection…
Publications
Other
G-Rex®24 Well Plate, G-Rex®6 Well Plate
Publication Date: January 1, 2022
Expanding cytokine-induced killer (CIK) cells in a gas-permeable G-Rex® plate produced more cells than a conventional 24-well plate, with similar phenotype and cytotoxicity. From 1 × 10^6 PBMCs per well (three healthy donors), 14-day G-Rex® 24-well cultures reached 110 × 10^6 total cells and 17 × 10^6 NK-T cells, versus 73 × 10^6 and 9 × 10^6 in standard plates, and secreted more IFN-γ. Cell subsets, activation markers and killing of K562 and Kasumi leukemia cells did not differ significantly. Seeding 30 × 10^6 PBMCs in a G-Rex® 6-well plate yielded over 1 × 10^9 cells per run (mean 5.1 × 10^9) in 14 days. A GMP donor-derived product given to a patient with AML relapsed after allogeneic t…
Publications
Other
G-Rex®10M, G-Rex®500M
Publication Date: January 1, 2022
The study outlines improvements to the manufacturing of MT-401 (multiTAA-specific T cells). The new process using G-Rex® 10M and scaling to G-Rex® 500M reduced duration to 9 days and improved T cell purity and memory phenotype.
Publications
CAR T Cells
Publication Date: January 1, 2022
This poster introduces the Go-Rex device, built on G-Rex® technology, for long-term 3D tumor modeling. It allows assessment of T-cell migration, infiltration, and killing over extended periods compared to traditional assays.
Publications
NK Cells
G-Rex®6M Well Plate
Publication Date: January 1, 2022
Cord blood-derived NK cells were engineered non-virally into optimized-affinity CD38 CAR-NK cells with CRISPR/Cas9 CD38 knockout to prevent fratricide, for multiple myeloma. CD3-depleted cord blood mononuclear cells were expanded on irradiated EBV-LCL feeders with IL-2, electroporated with a Cas9 RNP against CD38 on day 5 and with TcBuster transposase mRNA plus a nanoplasmid carrying the CAR on day 7, then harvested on day 22. The product was over 96% CD56-positive, CD3-negative NK cells with over 85% CD38 knockout, over 80% transgene expression and 1 to 2 vector copies per cell. In G-Rex®6M plates the cells expanded about 400-fold by day 22. They killed MM.1S, H929, RPMI and NALM6 cells…
Publications
CAR T Cells
G-Rex®100M
Publication Date: January 1, 2022
G-Rex® vessels were validated as a replacement for Wave bioreactor culture bags to manufacture lentiviral CAR T cells when bag supply ran short. Mesothelin CAR T cells from consented patient material were produced in parallel in G-Rex® and Wave systems. G-Rex® products showed lower transduction efficiency at the same multiplicity of infection, yet expansion was at least 50-fold, viability exceeded 90%, and phenotypes were comparable. Cells from both processes mediated CAR-dependent cytotoxicity and cytokine production. A 1 L G-Rex® seeded with 50 million T cells yielded 2-4 billion cells, using one third of the starting material and one fifth of the media needed in the Wave, with less man…
Publications
CD34 Cells
G-Rex®24 Well Plate
Publication Date: January 1, 2022
A 24-well G-Rex® plate was tested as a culture system for lentivirally transduced human CD34+ hematopoietic stem progenitor cells, against a standard 12-well plate, ahead of vector copy number measurement. Thawed CD34+ cells were pre-stimulated in StemSpan AOF SFT3 medium at 4E+06 cells/mL, transduced the next day with the LG631MGMT v2b vector at MOI 20, and harvested on day 2 for viability, CD34 flow, CFU assay and ddPCR copy number. For liquid culture through day 14, 2 × 10^5 cells were seeded per G-Rex® well in 8 mL of IMDM with 20% FBS and seven cytokines, whereas the 12-well plate used 2 mL. The G-Rex® format required weekly rather than triweekly maintenance.
Publications
NK Cells
Publication Date: December 12, 2021
Engineering CD123-targeted natural killer cells to secrete IL-15 kept them functional against acute myeloid leukemia under repeated antigen exposure, but the modification caused lethal toxicity in one mouse model. Of nine CAR designs tested, those with 2B4.ζ or 4-1BB.ζ domains gave the strongest killing of MV-4-11 cells in vitro, yet only 2B4.ζ CAR-NK cells improved survival in mice, and only transiently. In a 10-day serial stimulation assay, IL-15-secreting cells persisted and kept killing, while unmodified and 2B4.ζ cells declined, and 2B4.ζ cytotoxicity was abrogated by day 5. In MV-4-11 mice, IL-15-secreting cells led to median survival of 21 to 26 days versus 49 untreated; in MOLM-13…
No manuscripts match your filters.